A prospective, randomized trial comparing 25-gauge and 22-gauge needles for endoscopic ultrasound-guided fine needle aspiration of pancreatic masses

2013 ◽  
Vol 48 (6) ◽  
pp. 752-757 ◽  
Author(s):  
Jun Kyu Lee ◽  
Kyu Taek Lee ◽  
E Ryoung Choi ◽  
Tae Hoon Jang ◽  
Kee-Taek Jang ◽  
...  
HPB ◽  
2020 ◽  
Vol 22 (5) ◽  
pp. 779-786 ◽  
Author(s):  
Spencer Cheng ◽  
Vitor O. Brunaldi ◽  
Mauricio K. Minata ◽  
Danielle A. Chacon ◽  
Eduardo B. da Silveira ◽  
...  

2011 ◽  
Vol 106 (9) ◽  
pp. 1705-1710 ◽  
Author(s):  
Julio Iglesias-Garcia ◽  
Enrique J Dominguez-Munoz ◽  
Ihab Abdulkader ◽  
Jose Larino-Noia ◽  
Elena Eugenyeva ◽  
...  

2015 ◽  
Vol 139 (10) ◽  
pp. 1248-1252 ◽  
Author(s):  
Judy C. Pang ◽  
Michael H. Roh

Metastatic lesions in the pancreas are very uncommon and may be difficult to differentiate from the more commonly encountered primary neoplasms derived from the exocrine and endocrine pancreas because of the significant overlap in clinical presentation, imaging, and cytologic features. Metastasis to the pancreas may occur years after treatment of the primary neoplasm and is often not considered on initial evaluation because of the rarity of such events. The possibility of a metastasis to the pancreas should be entertained in patients with any prior history of malignancy because a proper diagnosis is essential in identifying surgical candidates, or avoiding potentially unnecessary surgery and facilitating triage to more appropriate nonoperative therapy. Herein, we describe intrapancreatic metastases secondary to renal cell carcinoma, melanoma, and lung carcinoma, as documented by cytologic examination of endoscopic ultrasound-guided fine-needle aspiration of the pancreatic masses.


Sign in / Sign up

Export Citation Format

Share Document